Vertex Pharmaceuticals (VRTX) Q1 Earnings and Revenues Top Estimates

Vertex Pharmaceuticals (VRTX) came out with quarterly earnings of $4.76 per share, beating the Zacks Consensus Estimate of$ 4.10 per share. This compares to earnings of $3.05 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 16.10%. A quarter ago, it was expected that this drugmaker would post earnings of$ 4.10 per share when it actually produced earnings of $4.20, delivering a surprise of 2.44%.Over the last four quarters, the ...